Skip to main content
Screener/Healthcare/Biotechnology

VTGN — VistaGen Therapeutics, Inc.

NASDAQ
$0.63+0.02 (+2.71%)
Penny StockUnder $1Under $5Healthcare
$0.43
$5.14
$0.60
$0.64
EPS (TTM)$-1.90
P/E Ratio-0.38
Dividend Yield—
Market Cap$18.7M
Volume395K
Prev Close$0.61
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q3 '26$303K-$18.9M$-0.4537.6%-6237.3%
Q2 '26$258K-$19.4M$-0.54100.0%-7526.0%
Q1 '26$244K-$15.1M$-0.4730.7%-6186.5%
Q4 '25-$15K-$13.6M$-0.44100.0%90900.0%
Q3 '25$234K-$14.1M$-0.46100.0%-6020.9%
Q2 '25$183K-$13.0M$-0.42100.0%-7082.5%
Q1 '25$84K-$10.7M$-0.35100.0%-12777.4%
Q4 '24$197K-$9.5M$-0.35100.0%-4825.8%
Get Your Daily Market Recap